Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models.
暂无分享,去创建一个
[1] D. Ganten,et al. Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis , 2002, Journal of Molecular Medicine.
[2] D. Silversides,et al. Use of a Biological Peptide Pump to Study Chronic Peptide Hormone Action in Transgenic Mice , 2001, The Journal of Biological Chemistry.
[3] Y. Pinto,et al. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy , 2001, Journal of Molecular Medicine.
[4] T. Ichiki,et al. Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension , 2001, Circulation.
[5] H. Matsubara,et al. Apoptosis Is Not Increased in Myocardium Overexpressing Type 2 Angiotensin II Receptor in Transgenic Mice , 2001, Hypertension.
[6] D. Ganten,et al. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research , 2001, Journal of Molecular Medicine.
[7] D. Silversides,et al. Contribution of circulating renin to local synthesis of angiotensin peptides in the heart. , 2000, Physiological genomics.
[8] Y. Mori,et al. Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. , 2000, The Journal of biological chemistry.
[9] F. Gaffney,et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. , 2000, The Journal of clinical investigation.
[10] S. Eguchi,et al. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase , 2000, Regulatory Peptides.
[11] D. Dostal. The cardiac renin–angiotensin system: novel signaling mechanisms related to cardiac growth and function , 2000, Regulatory Peptides.
[12] C. Ruwhof,et al. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. , 2000, Cardiovascular research.
[13] N. Dali-Youcef,et al. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Ganten,et al. The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. , 2000, Hypertension.
[15] K. Baker,et al. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? , 1999, Circulation research.
[16] J. Sadoshima,et al. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro. , 1999, Circulation research.
[17] T. Inagami,et al. Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice. , 1999, The Journal of clinical investigation.
[18] D. Ganten,et al. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] Y. Toya,et al. Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[20] L. Mazzolai,et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. , 1998, Hypertension.
[21] A. Danser,et al. Localization and production of angiotensin II in the isolated perfused rat heart. , 1998, Hypertension.
[22] H. Matsubara,et al. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. , 1998, Circulation research.
[23] Q. Li,et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. , 1998, The Journal of clinical investigation.
[24] M. Zile,et al. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. , 1998, American journal of physiology. Heart and circulatory physiology.
[25] Y. Mori,et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. , 1998, The Journal of clinical investigation.
[26] J. Ménard,et al. Local angiotensin II generation in the rat heart: role of renin uptake. , 1998, Circulation research.
[27] Y. Mori,et al. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. , 1997, Circulation.
[28] A. Danser,et al. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. , 1997, Hypertension.
[29] H. Schunkert. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease , 1997, Journal of Molecular Medicine.
[30] G. Barsh,et al. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Fukamizu,et al. Stretch-induced MAP kinase activation in cardiomyocytes of angiotensinogen-deficient mice. , 1997, Biochemical and biophysical research communications.
[32] K. Weber,et al. Cultured myofibroblasts generate angiotensin peptides de novo. , 1997, Journal of molecular and cellular cardiology.
[33] T. Katsuya,et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. , 1997, Circulation.
[34] M. Boddi,et al. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. , 1996, Circulation.
[35] G. Booz,et al. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. , 1996, Hypertension.
[36] Y. Mori,et al. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. , 1996, Circulation research.
[37] J. Laragh,et al. Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site. , 1996, American journal of hypertension.
[38] A. Clerk,et al. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. , 1996, The Biochemical journal.
[39] R Aikawa,et al. Endothelin-1 Is Involved in Mechanical Stress-induced Cardiomyocyte Hypertrophy (*) , 1996, The Journal of Biological Chemistry.
[40] E. Sonnenblick,et al. Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. , 1995, The American journal of physiology.
[41] A. McCulloch,et al. Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts , 1995 .
[42] G. Booz,et al. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. , 1995, Cardiovascular research.
[43] N. Kim,et al. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. , 1995, The American journal of physiology.
[44] T. Suzuki,et al. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. , 1995, The American journal of physiology.
[45] E. Fleck,et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. , 1995, Circulation.
[46] A. Fukamizu,et al. Angiotensinogen-deficient mice with hypotension. , 1994, The Journal of biological chemistry.
[47] H. Schunkert,et al. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. , 1994, The American journal of physiology.
[48] A. Danser,et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. , 1994, Hypertension.
[49] P. Erne,et al. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. , 1994, The Journal of clinical investigation.
[50] F. Marumo,et al. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. , 1994, Circulation.
[51] H. Matsubara,et al. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. , 1994, The Journal of clinical investigation.
[52] J. Sadoshima,et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro , 1993, Cell.
[53] D. Campbell,et al. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. , 1993, Hypertension.
[54] M. Schambelan,et al. Characterization of angiotensin II receptor subtypes in rat heart. , 1992, Circulation research.
[55] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[56] K. Rothblum,et al. Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. , 1992, The American journal of physiology.
[57] K. Swedberg,et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.
[58] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[59] A. Danser,et al. Production of angiotensins I and II at tissue sites in intact pigs. , 1992, The American journal of physiology.
[60] J. Higaki,et al. Role of Cardiac Angiotensin II in Isoproterenol‐Induced Left Ventricular Hypertrophy , 1992, Hypertension.
[61] K. Fuxe,et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. , 1992, The EMBO journal.
[62] N. Niedermaier,et al. 110. Left ventricular hypertrophy and myocardial infarction increase left ventricular angiotensinogen gene expression , 1991 .
[63] M. Pahor,et al. Enalapril Prevents Cardiac Fibrosis and Arrhythmias in Hypertensive Rats , 1991, Hypertension.
[64] T. Ogihara,et al. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. , 1991, Journal of hypertension.
[65] J. S. Janicki,et al. Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy , 1991, Circulation.
[66] G. Gamble,et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition , 1991, The Lancet.
[67] K Lindpaintner,et al. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. , 1991, Circulation research.
[68] K. Misono,et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. , 1990, The Journal of biological chemistry.
[69] K. Baker,et al. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. , 1990, The American journal of physiology.
[70] B. Healy,et al. Angiotensin II receptors in normal and failing human hearts. , 1989, The Journal of clinical endocrinology and metabolism.
[71] K. Arakawa,et al. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart. , 1989, Japanese heart journal.
[72] D. Ganten,et al. Angiotensinogen gene expression in extrahepatic rat tissues: Application of a solution hybridization assay , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.
[73] G. Lamas,et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.
[74] N. Sharpe,et al. TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 1988, The Lancet.
[75] T. Brody,et al. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. , 1987, Endocrinology.
[76] V. Dzau. Implications of local angiotensin production in cardiovascular physiology and pharmacology. , 1987, The American journal of cardiology.
[77] J. Habener,et al. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. , 1986, The Journal of clinical investigation.
[78] T. Rogers,et al. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. , 1986, The Journal of pharmacology and experimental therapeutics.
[79] B. Wintroub,et al. The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G. , 1982, The Journal of biological chemistry.
[80] R. Tarazi,et al. Effect of Converting Enzyme Inhibitor (SQ14,225) on Myocardial Hypertrophy in Spontaneously Hypertensive Rats , 1980, Hypertension.
[81] D. Ganten,et al. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade , 2004, Molecular and Cellular Biochemistry.
[82] Y. Yazaki,et al. Molecular basis of cardiac hypertrophy , 2000, Zeitschrift für Kardiologie.
[83] R. A. Rutherford,et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. , 1998, The Journal of pharmacology and experimental therapeutics.
[84] K. Weber,et al. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. , 1995, Cardiovascular research.